SCHEMBL345298

SCHEMBL345298

C=C(C)OC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27773873 0.97
SCHEMBL27547952 0.73
SCHEMBL29209904 0.73
SCHEMBL586697 0.73
SCHEMBL27996554 0.72
SCHEMBL10629361 0.72
SCHEMBL1572164 0.71
SCHEMBL28188437 0.71
SCHEMBL28111998 0.71
SCHEMBL12560918 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 440 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7892449-B2 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2011-02-22 US claimed
CN-101665426-A Method for preparing 2-alkyl carboxylic acid SHANGHAI RECORD CHEMICAL S & T 2010-03-10 CN claimed
US-7425394-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2008-09-16 US claimed
US-20070026165-A1 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2007-02-01 US claimed
US-20050266177-A1 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2005-12-01 US claimed
EP-0657166-B1 Combination containing a quinoxaline and a nucleoside AVENTIS PHARMA GMBH (DE) 2003-04-09 EP claimed
US-6369057-B1 VIRICIDES, IN PARTICULAR AGAINST RETROVIRUSES, HUMAN IMMUNODEFICIENCY VIRUS (HIV) AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-09 US claimed
EP-0509398-B1 Quinoxalines, process for their preparation and their use AVENTIS PHARMA GMBH (DE) 2001-09-19 EP claimed
US-6265418-B1 ANTICOAGULANTS UBE INDUSTRIES, LTD. (JP) 2001-07-24 US claimed
EP-1020467-A1 N-ACYLAMINO ACID AMIDE COMPOUNDS AND INTERMEDIATES FOR PREPARATION THEREOF UBE INDUSTRIES LIMITED (JP) 2000-07-19 EP claimed
EP-0977570-A1 QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS BAYER AG (DE) 2000-02-09 EP claimed
WO-1998032442-A1 QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-30 WO claimed
WO-1998017656-A1 A FAMILY OF CANADENSOL TAXANES, THE SEMI-SYNTHETIC PREPARATION AND THERAPEUTIC USE THEREOF INSTITUTE ARMAND-FRAPPIER (CA) 1998-04-30 WO claimed
EP-0728481-A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections BAYER AG (DE) 1996-08-28 EP claimed
US-5480879-A ANTIBACTERIAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-01-02 US claimed
EP-0592868-A1 Quinolonecarboxylic acids BAYER AG (DE) 1994-04-20 EP claimed
EP-0591808-A1 Quinolonecarboxylic acids BAYER AG (DE) 1994-04-13 EP claimed
EP-0509398-A1 Quinoxalines, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-21 EP claimed
US-4736055-A STARING MATERIAL FOR PHOTORESIST POLYMERS CIBA-GEIGY CORPORATION (US) 1988-04-05 US claimed
JP-6250392-A None JP disclosed
JP-6250391-A None JP disclosed
JP-10310546-A None JP disclosed
EP-4596230-A1 MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC Mitsubishi Chemical Corporation (JP) 2025-08-06 EP disclosed
US-20250178327-A1 MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC MITSUBISHI CHEMICAL CORPORATION (JP) 2025-06-05 US disclosed
CN-119731020-A Multilayer structure, method for producing same, automobile component, aircraft component, and vibration-resistant material for carbon fiber reinforced plastic 三菱化学株式会社 2025-03-28 CN disclosed
WO-2024157637-A1 LAMINATE AND IMAGE DISPLAY DEVICE 株式会社ダイセル 2024-08-02 WO disclosed
WO-2024135086-A1 PHOTOCURABLE COMPOSITION, UNDERCOAT LAYER, LAMINATE AND DISPLAY DEVICE 株式会社ダイセル 2024-06-27 WO disclosed
EP-4371979-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2024-05-22 EP disclosed
WO-2024071139-A1 MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC 三菱ケミカル株式会社 2024-04-04 WO disclosed
US-11898057-B2 Weather-resistant hard coat composition for glass-substitute substrate, cured product, and laminate DAICEL CORPORATION (JP) 2024-02-13 US disclosed
US-11866608-B2 Weather-resistant hard coat composition for metal, cured product, and coated metal substrate DAICEL CORPORATION (JP) 2024-01-09 US disclosed
US-11810713-B2 Rare earth magnet precursor or rare earth magnet molded body having roughened structure on surface and method for manufacturing same Daicel Miraizu Ltd. (JP) 2023-11-07 US disclosed
WO-2023163111-A1 POLYETHER RESIN 味の素株式会社 2023-08-31 WO disclosed
CN-116528867-A Compounds for the treatment of Alzheimer's disease 艾伯塔大学理事会 2023-08-01 CN disclosed
US-20230110603-A1 3-ALKOXYBENZAMIDE DERIVATIVE, AND PEST CONTROL AGENT KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2023-04-13 US disclosed
US-20230086403-A1 LAMINATE, HARD COATING FILM, AND COATING MATERIAL COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-03-23 US disclosed
WO-2023038123-A1 ADHESIVE-LAYER-EQUIPPED SUBSTRATE, LAMINATE, AND COATING COMPOSITION 旭化成株式会社 2023-03-16 WO disclosed
WO-2023286855-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT クミアイ化学工業株式会社 2023-01-19 WO disclosed
EP-4119618-A1 ALUMINUM PIGMENT WITH ADHERENT RESINOUS COMPOUND AND PRODUCTION METHOD THEREFOR Asahi Kasei Kabushiki Kaisha (JP) 2023-01-18 EP disclosed
EP-4116085-A1 LAMINATE, HARD-COAT COATING FILM, AND COATING MATERIAL COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2023-01-11 EP disclosed
EP-4098650-A1 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2022-12-07 EP disclosed
CN-112300100-B Preparation method of furfuryl alcohol ester 中国科学技术大学 2022-09-30 CN disclosed
CN-115052856-A 3-alkoxybenzamide derivative and pest control agent 组合化学工业株式会社 2022-09-13 CN disclosed
US-11384112-B2 Artificial nucleoside and artificial nucleotide, and artificial oligonucleotide TOKYO INSTITUTE OF TECHNOLOGY (JP) 2022-07-12 US disclosed
US-20220084746-A1 RARE EARTH MAGNET PRECURSOR OR RARE EARTH MAGNET MOLDED BODY HAVING ROUGHENED STRUCTURE ON SURFACE AND METHOD FOR MANUFACTURING SAME Daicel Miraizu Ltd. (JP) 2022-03-17 US disclosed
US-20220017777-A1 WEATHER-RESISTANT HARD COAT COMPOSITION FOR METAL, CURED PRODUCT, AND COATED METAL SUBSTRATE DAICEL CORPORATION (JP) 2022-01-20 US disclosed
US-20220017776-A1 WEATHER-RESISTANT HARD COAT COMPOSITION FOR GLASS-SUBSTITUTE SUBSTRATE, CURED PRODUCT, AND LAMINATE DAICEL CORPORATION (JP) 2022-01-20 US disclosed
EP-3093300-B1 AQUEOUS COMPOSITE PARTICLE DISPERSION ASAHI CHEMICAL IND (JP) 2021-11-24 EP disclosed
EP-3905284-A1 RARE EARTH MAGNET PRECURSOR OR RARE EARTH MAGNET MOLDING HAVING ROUGHENED STRUCTURE ON SURFACE AND METHOD FOR MANUFACTURING SAME Daicel Miraizu Ltd. (JP) 2021-11-03 EP disclosed
US-20210324232-A1 HARD COATING FILM, HARD COATING FILM-APPLIED SUBSTRATE, COATING MATERIAL COMPOSITION, AND WINDOW MATERIAL ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-10-21 US disclosed
EP-3885054-A1 WEATHER-RESISTANT HARD COAT COMPOSITION FOR METAL, CURED PRODUCT AND COATED METAL SUBSTRATE Daicel Corporation (JP) 2021-09-29 EP disclosed
EP-3885053-A1 WEATHER-RESISTANT HARD COAT COMPOSITION FOR GLASS-SUBSTITUTE SUBSTRATE, CURED PRODUCT AND LAYERED PRODUCT Daicel Corporation (JP) 2021-09-29 EP disclosed
CN-113228207-A Rare earth magnet precursor or rare earth magnet molded body having roughened surface structure on surface, and method for producing same 大赛璐美华株式会社 2021-08-06 CN disclosed
WO-2021153720-A1 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT クミアイ化学工業株式会社 2021-08-05 WO disclosed
CN-113165014-A Weather-resistant hard coating composition for metal, cured product, and coated metal substrate 株式会社大赛璐 2021-07-23 CN disclosed
CN-113165015-A Weather-resistant hard coating composition for glass-substitute substrate, cured product, and laminate 株式会社大赛璐 2021-07-23 CN disclosed
EP-3845619-A1 HARD COATING FILM, BASE MATERIAL WITH HARD COATING FILM, COATING COMPOSITION AND WINDOW MATERIAL Asahi Kasei Kabushiki Kaisha (JP) 2021-07-07 EP disclosed
US-20210188894-A1 ARTIFICIAL NUCLEOSIDE AND ARTIFICIAL NUCLEOTIDE, AND ARTIFICIAL OLIGONUCLEOTIDE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2021-06-24 US disclosed
EP-3498794-B1 COATING COMPOSITION DISPERSION, AQUEOUS DISPERSION OF COMPOSITE-PARTICLES, AND METHOD FOR PRODUCING AQUEOUS DISPERSION OF COMPOSITE-PARTICLES ASAHI CHEMICAL IND (JP) 2021-02-10 EP disclosed
CN-112300100-A Preparation method of furfuryl alcohol ester 中国科学技术大学 2021-02-02 CN disclosed
CN-112208172-A Composite molded body and method for producing same 大赛璐美华株式会社 2021-01-12 CN disclosed
EP-3708625-A1 PROCESS FOR PRODUCING AQUEOUS COMPOSITE-PARTICLE DISPERSION Asahi Kasei Kabushiki Kaisha (JP) 2020-09-16 EP disclosed
US-20200121652-A1 COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT THE DOSHISHA (JP) 2020-04-23 US disclosed
EP-3639855-A1 COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT The Doshisha (JP) 2020-04-22 EP disclosed
CN-110964382-A Pigment dispersion and application thereof in environment-friendly photosensitive composition 常州格林感光新材料有限公司 2020-04-07 CN disclosed
CN-110964374-A Antifogging application of radiation-curable composition 常州格林感光新材料有限公司 2020-04-07 CN disclosed
CN-110964383-A Radiation curing composition 常州格林感光新材料有限公司 2020-04-07 CN disclosed
WO-2020067248-A1 NITRIDE-BASED NONMAGNETIC CERAMIC MOLDING HAVING ROUGHENED STRUCTURE ON THE SURFACE THEREOF, AND METHOD FOR PRODUCING SAME ダイセルポリマー株式会社 2020-04-02 WO disclosed
WO-2020067249-A1 NONMAGNETIC CERAMIC MOLDED BODY HAVING ROUGHENED STRUCTURE ON SURFACE AND METHOD FOR PRODUCING SAME ダイセルポリマー株式会社 2020-04-02 WO disclosed
WO-2020067308-A1 NITRIDE-BASED NONMAGNETIC CERAMIC MOLDING AND METHOD FOR PRODUCING SAME ダイセルポリマー株式会社 2020-04-02 WO disclosed
US-20200072823-A1 Enzyme-Amplified Redox Micoarray Detection Process CUSTOMARRAY, INC. (US) 2020-03-05 US disclosed
WO-2020045632-A1 HARD COATING FILM, BASE MATERIAL WITH HARD COATING FILM, COATING COMPOSITION AND WINDOW MATERIAL 旭化成株式会社 2020-03-05 WO disclosed
EP-3603563-A1 MEDICAL APPARATUS AND METHOD FOR MANUFACTURING SAME Daicel Polymer Ltd. (JP) 2020-02-05 EP disclosed
US-20200031067-A1 MEDICAL APPARATUS AND METHOD FOR MANUFACTURING SAME DAICEL POLYMER LTD. (JP) 2020-01-30 US disclosed
US-10427125-B2 Methods for performing patterned chemistry ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-10-01 US disclosed
WO-2019179460-A1 RADIATION-CURABLE GRAVURE INK 常州格林感光新材料有限公司 2019-09-26 WO disclosed
EP-3498794-A1 COATING COMPOSITION DISPERSION, AQUEOUS COMPOSITE-PARTICLE DISPERSION, AND PROCESS FOR PRODUCING AQUEOUS COMPOSITE-PARTICLE DISPERSION ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-06-19 EP disclosed
US-20190169458-A1 COATING COMPOSITION DISPERSION, AQUEOUS DISPERSION OF COMPOSITE PARTICLES AND METHOD FOR PRODUCING AQUEOUS DISPERSION OF COMPOSITE PARTICLES ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-06-06 US disclosed
US-10294526-B2 Polymer co-location in surface-attached biopolymers and arrays of biopolymers INTEL CORPORATION (US) 2019-05-21 US disclosed
CN-105960441-B It is used to form the coating composition of the film with impact resistance 关西涂料株式会社 2019-04-16 CN disclosed
EP-3418289-A1 ARTIFICIAL NUCLEOSIDE AND ARTIFICIAL NUCLEOTIDE, AND ARTIFICIAL OLIGONUCLEOTIDE Tokyo Institute of Technology (JP) 2018-12-26 EP disclosed
CN-108368373-A Coating composition and coated-body 旭硝子株式会社 2018-08-03 CN disclosed
US-10035147-B2 Wafer with gel-based biochips for electrochemical synthesis and electrical detection of polymers INTEL CORPORATION (US) 2018-07-31 US disclosed
US-10023760-B2 Semicarbazide composition, method for producing semicarbazide composition, aqueous polymer composition and composite ASAHI KASEI CHEMICALS CORPORATION (JP) 2018-07-17 US disclosed
US-20170356044-A1 POLYMER CO-LOCATION IN SURFACE-ATTACHED BIOPOLYMERS AND ARRAYS OF BIOPOLYMERS INTEL CORP (US) 2017-12-14 US disclosed
US-9834520-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-12-05 US disclosed
EP-3225644-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF Daicel Corporation (JP) 2017-10-04 EP disclosed
US-9751827-B2 Method for alkylation of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-09-05 US disclosed
US-9745628-B2 Polymer co-location in surface-attached biopolymers and arrays of biopolymers INTEL CORPORATION (US) 2017-08-29 US disclosed
CN-105086726-B Aqueous coating agent composition, water paint, film and coated articles 旭化成株式会社 2017-08-18 CN disclosed
CN-104812735-B Semicarbazide composition, method for producing semicarbazide composition, aqueous resin composition, and composite 旭化成株式会社 2017-03-22 CN disclosed
EP-2368947-B1 Ink composition SEIKO EPSON CORP (JP) 2016-12-21 EP disclosed
US-9499578-B2 Massively parallel synthesis of biopolymeric arrays INTEL CORPORATION (US) 2016-11-22 US disclosed
US-20160333189-A1 AQUEOUS COMPOSITE PARTICLE DISPERSION ASAHI KASEI KABUSHIKI KAISHA (JP) 2016-11-17 US disclosed
EP-3093300-A1 AQUEOUS COMPOSITE PARTICLE DISPERSION Asahi Kasei Kabushiki Kaisha (JP) 2016-11-16 EP disclosed
US-9458199-B2 Antigen surrogates in autoimmune disease OPKO PHARMACEUTICALS, LLC (US) 2016-10-04 US disclosed
CN-105960441-A Coating composition for forming coating film having impact resistance 关西涂料株式会社 2016-09-21 CN disclosed
US-20160229814-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-08-11 US disclosed
CN-105518039-A Acid-modified epoxidized vegetable oil and (meth)acrylic copolymer curable or cured compositions 3M INNOVATIVE PROPERTIES CO 2016-04-20 CN disclosed
US-20160060235-A1 Therapeutic Agent for Type 2 Diabetes NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) 2016-03-03 US disclosed
WO-2016012333-A1 PESTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-01-28 WO disclosed
EP-2975031-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-01-20 EP disclosed
US-20160009632-A1 METHOD FOR ALKYLATION OF AMINES TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-01-14 US disclosed
EP-2966057-A1 METHOD FOR ALKYLATION OF AMINES Takasago International Corporation (JP) 2016-01-13 EP disclosed
US-9219123-B2 Method of producing a nitride semiconductor crystal with precursor containing carbon and oxygen, and nitride semiconductor crystal and semiconductor device made by the method SHARP KABUSHIKI KAISHA (JP) 2015-12-22 US disclosed
US-9163102-B2 Soluble branched polymers ISP INVESTMENTS INC. (US) 2015-10-20 US disclosed
US-20150291831-A1 SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS POLYMER COMPOSITION AND COMPOSITE ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-10-15 US disclosed
EP-2921474-A1 SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS RESIN COMPOSITION AND COMPOSITE Asahi Kasei Chemicals Corporation (JP) 2015-09-23 EP disclosed
US-9120776-B2 Condensed heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-09-01 US disclosed
US-20150232620-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF DAICEL CORPORATION (JP) 2015-08-20 US disclosed
US-20150231633-A1 GEL-BASED BIO CHIP FOR ELECTROCHEMICAL SYNTHESIS AND ELECTRICAL DETECTION OF POLYMERS INTEL CORP (US) 2015-08-20 US disclosed
EP-2907833-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF Daicel Corporation (JP) 2015-08-19 EP disclosed
US-9096953-B2 Method for high throughput, high volume manufacturing of biomolecule micro arrays INTEL CORPORATION (US) 2015-08-04 US disclosed
US-20150212032-A1 METHOD AND APPARATUS FOR MATCH QUALITY ANALYSIS OF ANALYTE BINDING INTEL CORPORATION 2015-07-30 US disclosed
US-9085461-B2 Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis INTEL CORPORATION (US) 2015-07-21 US disclosed
US-20150141296-A1 METHODS FOR PERFORMING PATTERNED CHEMISTRY The Arizona Board of Regents, A Body Corporate of the State of Arizona, acting for and on behalf of (US) 2015-05-21 US disclosed
EP-2266978-B1 Novel physiologically active substances EISAI R&D MAN CO LTD (JP) 2015-05-20 EP disclosed
US-9029572-B2 3-hydroxy-6H-benzo [C] chromene-6-one derivative and manufacturing method thereof SANTEN PHARMACEUTICAL CO., LTD. (JP) 2015-05-12 US disclosed
EP-1548121-B1 Physiologically active substances EISAI R&D MAN CO LTD (JP) 2015-04-29 EP disclosed
US-8999724-B2 Method and apparatus for match quality analysis of analyte binding INTEL CORPORATION (US) 2015-04-07 US disclosed
US-8981040-B2 Cationically polymerizable resin, cationically polymerizable resin composition, and cured products thereof DAICEL CORPORATION (JP) 2015-03-17 US disclosed
US-8975256-B2 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity SANTEN PHARMACEUTICAL CO., LTD. (JP) 2015-03-10 US disclosed
US-8940143-B2 Gel-based bio chip for electrochemical synthesis and electrical detection of polymers INTEL CORPORATION (US) 2015-01-27 US disclosed
EP-1849796-B1 ANTI-PENICILLIN RESISTANT PNEUMOCOCCI AGENT AND NOVEL 16-MEMBERED RING MACROLIDE DERIVATIVE MICROBIAL CHEM RES FOUND (JP) 2014-11-05 EP disclosed
US-20140303313-A1 SOLUBLE BRANCHED POLYMERS ISP INVESTMENTS INC. (US) 2014-10-09 US disclosed
US-20140296540-A1 3-HYDROXY-6H-BENZO [C] CHROMENE-6-ONE DERIVATIVE AND MANUFACTURING METHOD THEREOF AYUMI PHARMACEUTICAL CORPORATION (JP) 2014-10-02 US disclosed
US-20140228409-A1 CONDENSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-08-14 US disclosed
US-8802869-B2 3-hydroxy-6H-benzo [c] chromene-6-one derivative and manufacturing method thereof SANTEN PHARMACEUTICAL CO., LTD. (JP) 2014-08-12 US disclosed
US-20140213484-A1 POLYMER CO-LOCATION IN SURFACE-ATTACHED BIOPOLYMERS AND ARRAYS OF BIOPOLYMERS INTEL CORPORATION 2014-07-31 US disclosed
EP-2759533-A1 CONDENSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2014-07-30 EP disclosed
CN-103880860-A Novel Adduct Compound And Manufacturing Method Thereof TEIJIN LTD 2014-06-25 CN disclosed
US-8759259-B2 Compositions and methods for producing cyclic peptoid libraries THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-06-24 US disclosed
US-20140145202-A1 NITRIDE SEMICONDUCTOR CRYSTAL SHARP KABUSHIKI KAISHA (JP) 2014-05-29 US disclosed
US-20140147455-A1 ANTIGEN SURROGATES IN AUTOIMMUNE DISEASE OPKO PHARMACEUTICALS, LLC (US) 2014-05-29 US disclosed
US-8735462-B2 Radical-polymerizable resin, radical-polymerizable resin composition, and cured material thereof DAICEL CORPORATION (JP) 2014-05-27 US disclosed
US-8697605-B2 Polymer co-location in surface-attached biopolymers and arrays of biopolymers INTEL CORPORATION (US) 2014-04-15 US disclosed
US-8647821-B2 Method and apparatus for combined electrochemical synthesis and detection of analytes INTEL CORPORATION (US) 2014-02-11 US disclosed
US-8614086-B2 Quality control methods for the manufacture of polymer arrays INTEL CORPORATION (US) 2013-12-24 US disclosed
EP-2674422-A1 3-HYDROXY-6H-BENZO[C]CHROMEN-6-ONE DERIVATIVE AND METHOD FOR PRODUCING SAME SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-12-18 EP disclosed
US-8603803-B2 Solid phase electrochemical synthesis with controlled product cleavage INTEL CORPORATION (US) 2013-12-10 US disclosed
US-8603756-B2 Antigen surrogates in autoimmune disease OPKO PHARMACEUTICALS, LLC (US) 2013-12-10 US disclosed
EP-1944290-B1 NOVEL 1-2-DIHYDROQUINOLINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY SANTEN PHARMACEUTICAL CO LTD (JP) 2013-12-04 EP disclosed
US-20130315553-A1 APPARATUS FOR PRODUCING OPTICAL FIBER, METHOD FOR PRODUCING OPTICAL FIBER, AND OPTICAL FIBER PRODUCED BY METHOD DAICEL CORPORATION (JP) 2013-11-28 US disclosed
US-20130310576-A1 3-HYDROXY-6H-BENZO [C] CHROMENE-6-ONE DERIVATIVE AND MANUFACTURING METHOD THEREOF SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-11-21 US disclosed
EP-2663321-A2 ANTIGEN SURROGATES IN AUTOIMMUNE DISEASE OPKO Pharmaceuticals, LLC (US) 2013-11-20 EP disclosed
US-20130303537-A1 1,2,3,4-TETRAHYDROQUINOXALINE COMPOUNDS HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-11-14 US disclosed
US-8551991-B2 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-10-08 US disclosed
US-8507453-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2013-08-13 US disclosed
US-20130186767-A1 METHOD AND APPARATUS FOR COMBINED ELECTROCHEMICAL SYNTHESIS AND DETECTION OF ANALYTES CASTRO HERNAN ADOLFO (US) 2013-07-25 US disclosed
US-8486631-B2 Quality control methods for the manufacture of polymer arrays INTEL CORPORATION (US) 2013-07-16 US disclosed
US-20130165350-A1 SURFACE LINKERS FOR ARRAY SYNTHESIS AFFYMETRIX, INC. (US) 2013-06-27 US disclosed
US-8470859-B2 Iminopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-06-25 US disclosed
WO-2013082359-A1 SOLUBLE BRANCHED POLYMERS ISP INVESTMENTS INC. (US) 2013-06-06 WO disclosed
US-8420635-B2 Method for preventing or treating a glucocorticoid receptor-related disease SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-04-16 US disclosed
US-8410027-B2 Density modification in arrays of surface-attached nucleic acid molecules INTEL CORPORATION (US) 2013-04-02 US disclosed
US-20130035465-A1 RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF DAICEL CORPORATION (JP) 2013-02-07 US disclosed
US-20130030078-A1 RADICAL-POLYMERIZABLE RESIN, RADICAL-POLYMERIZABLE RESIN COMPOSITION, AND CURED MATERIAL THEREOF DAICEL CORPORATION (JP) 2013-01-31 US disclosed
US-8338097-B2 Method and apparatus for combined electrochemical synthesis and detection of analytes INTEL CORPORATION (US) 2012-12-25 US disclosed
EP-2535330-A2 Iminopyridine derivative and use thereof Takeda Pharmaceutical Company Limited (JP) 2012-12-19 EP disclosed
US-20120309930-A1 CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF DAICEL CORPORATION (JP) 2012-12-06 US disclosed
WO-2012154594-A1 METHODS FOR PERFORMING PATTERNED CHEMISTRY WOODBURY NEAL (US) 2012-11-15 WO disclosed
EP-1995242-B1 NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY SANTEN PHARMACEUTICAL CO LTD (JP) 2012-11-07 EP disclosed
US-8278121-B2 Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis INTEL CORPORATION (US) 2012-10-02 US disclosed
US-20120225512-A1 METHOD AND APPARATUS TO FABRICATE POLYMER ARRAYS ON PATTERNED WAFERS USING ELECTROCHEMICAL SYNTHESIS INTEL CORPORATION 2012-09-06 US disclosed
US-20120219574-A1 ANTIGEN SURROGATES IN AUTOIMMUNE DISEASE OPKO PHARMACEUTICALS, LLC (US) 2012-08-30 US disclosed
US-20120220482-A1 COMPOSITIONS AND METHODS FOR SCREENING PEPTOID LIBRARIES THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-08-30 US disclosed
EP-2488543-A1 COMPOSITIONS AND METHODS FOR PRODUCING CYCLIC PEPTOID LIBRARIES The Board of Regents of The University of Texas System (US) 2012-08-22 EP disclosed
WO-2012096893-A2 ANTIGEN SURROGATES IN AUTOIMMUNE DISEASE OPKO PHARMACEUTICALS, LLC (US) 2012-07-19 WO disclosed
CN-102548998-A Novel addition compound, method for purifying and producing condensed polycyclic aromatic compound, solution for forming organic semiconductor film, and novel alpha-diketone compound TEIJIN LTD 2012-07-04 CN disclosed
US-20120070930-A1 METHOD AND APPARATUS TO FABRICATE POLYMER ARRAYS ON PATTERNED WAFERS USING ELECTROCHEMICAL SYNTHESIS INTEL CORPORATION 2012-03-22 US disclosed
US-8139189-B2 Liquid crystal display having particular oblique vapor deposition-alignment layer with ferroelectric liquid crystal DAI NIPPON PRINTING CO., LTD. (JP) 2012-03-20 US disclosed
US-20120015896-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2012-01-19 US disclosed
US-20110319644-A1 PROCESS FOR PRODUCTION OF 1-HYDROXY-19-NORCYCLOVITAMIN D DERIVATIVE AND INTERMEDIATE FOR THE PRODUCTION MERCIAN CORPORATION (JP) 2011-12-29 US disclosed
US-20110315559-A1 QUALITY CONTROL METHODS FOR THE MANUFACTURE OF POLYMER ARRAYS HOLT GORDON (US) 2011-12-29 US disclosed
US-8084202-B2 Optical detection for electronic microarrays INTEL CORPORATION (US) 2011-12-27 US disclosed
US-8062841-B2 Multiplex data collection and analysis in bioanalyte detection INTEL CORPORATION (US) 2011-11-22 US disclosed
US-8053774-B2 Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis INTEL CORPORATION (US) 2011-11-08 US disclosed
US-8053418-B2 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2011-11-08 US disclosed
US-20110263589-A1 Method for preventing or treating a glucocorticoid receptor-related disease SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-10-27 US disclosed
EP-2368947-A1 Ink composition Seiko Epson Corporation (JP) 2011-09-28 EP disclosed
US-20110224092-A1 METHOD AND APPARATUS FOR COMBINED ELECTROCHEMICAL SYNTHESIS AND DETECTION OF ANALYTES INTEL CORPORATION (US) 2011-09-15 US disclosed
US-8017775-B2 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-09-13 US disclosed
US-8009266-B2 Process for producing liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2011-08-30 US disclosed
US-7993907-B2 Microarrays; gene expression inhibition; drug-gene-protein-biology (dgpb) database; antiallergens; antiarthritic agents, antiinflammatory agents; cytokines; anticarcinogenic agents MOWYCAL LENDING, LLC (US) 2011-08-09 US disclosed
US-7985502-B2 Containing formic ester additive; cycling properties, electrical capacity, storage during charging UBE INDUSTRIES, LTD. (JP) 2011-07-26 US disclosed
US-20110136694-A1 DENSITY MODIFICATION IN ARRAYS OF SURFACE-ATTACHED NUCLEIC ACID MOLECULES GAO YUAN 2011-06-09 US disclosed
US-20110136902-A1 12-MEMBERED-RING MACROLACTAM DERIVATIVES MIYANO MASAYUKI 2011-06-09 US disclosed
US-20110118236-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-19 US disclosed
EP-1966230-B1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS INTEL CORP (US) 2011-05-18 EP disclosed
WO-2011054171-A1 TYROSINE DERIVATIVE HISTONE DEACETYLASES INHIBITORS AND APPLICATIONS THEREOF 寿光富康制药有限公司 (CN) 2011-05-12 WO disclosed
US-7932083-B2 Ferrodoxins; hydroxylases; self-replicating plasmid MERCIAN CORPORATION (JP) 2011-04-26 US disclosed
WO-2011047257-A1 COMPOSITIONS AND METHODS FOR PRODUCING CYCLIC PEPTOID LIBRARIES THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-04-21 WO disclosed
US-20110092384-A1 COMPOSITIONS AND METHODS FOR PRODUCING CODED PEPTOID LIBRARIES THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-04-21 US disclosed
US-7923237-B2 Using capacitance variance to detect receptor/biopolymer binding; screening for protein interactions; drug screening and molecular recognition; biochips INTEL CORPORATION (US) 2011-04-12 US disclosed
US-7919523-B2 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS, INC. (US) 2011-04-05 US disclosed
US-7911562-B2 Liquid crystal display and process for producing the same DAI NIPPON PRINTING CO., LTD. (JP) 2011-03-22 US disclosed
US-7907247-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2011-03-15 US disclosed
US-7893068-B2 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy MERCIAN CORPORATION (JP) 2011-02-22 US disclosed
US-7892449-B2 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2011-02-22 US disclosed
EP-1478619-B1 A PROCESS FOR PREPARING A PHENYLALANINE DERIVATIVE AND INTERMEDIATES THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2011-01-12 EP disclosed
EP-2269990-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-01-05 EP disclosed
EP-2266978-A1 Novel physiologically active substances MERCIAN CORPORATION (JP) 2010-12-29 EP disclosed
WO-2010133000-A1 SELECTIVE CASPASE INHIBITORS AND USES THEREOF NEW WORLD LABORATORIES INC. (CA) 2010-11-25 WO disclosed
EP-1715371-B1 LIQUID CRYSTAL DISPLAY DEVICE DAINIPPON PRINTING CO LTD (JP) 2010-11-03 EP disclosed
US-20100261287-A1 Method and apparatus for match quality analysis of analyte binding INTEL CORPORATION 2010-10-14 US disclosed
US-20100248975-A1 Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities INTEL CORPORATION 2010-09-30 US disclosed
US-20100240555-A1 Method for high throughput, high volume manufacturing of biomolecule micro arrays INTEL CORPORATION 2010-09-23 US disclosed
US-7777847-B2 Liquid crystal display and manufacturing method of the same DAI NIPPON PRINTING CO., LTD. (JP) 2010-08-17 US disclosed
US-7772249-B2 Imidazo[1,2-b]pyridazine compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-10 US disclosed
US-20100197919-A1 METHOD FOR PRODUCING MACROLIDE COMPOUND AND PRODUCTION INTERMEDIATE THEREOF MERCIAN CORPORATION (JP) 2010-08-05 US disclosed
EP-1517881-B1 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-02 EP disclosed
US-20100086931-A1 METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING DECREASE IN GENE EXPRESSION LEVEL AS INDEX EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-04-08 US disclosed
EP-2168961-A1 PROCESS FOR PRODUCING MACROLIDE COMPOUND AND INTERMEDIATE THEREFOR Eisai R&D Management Co., Ltd. (JP) 2010-03-31 EP disclosed
US-20100060844-A1 PROCESS FOR PRODUCING LIQUID CRYSTAL DISPLAY DAI NIPPON PRINTING CO., LTD. (JP) 2010-03-11 US disclosed
CN-101665426-A Method for preparing 2-alkyl carboxylic acid SHANGHAI RECORD CHEMICAL S & T 2010-03-10 CN disclosed
CN-101665426-A Method for preparing 2-alkyl carboxylic acid SHANGHAI RECORD CHEMICAL S & T 2010-03-10 CN disclosed
CN-101665426-A Method for preparing 2-alkyl carboxylic acid SHANGHAI RECORD CHEMICAL S & T 2010-03-10 CN disclosed
US-20100035771-A1 Molecular microarrays and helical peptides CABEZAS EDELMIRA 2010-02-11 US disclosed
US-7655442-B2 Efficiently producing a macrolide compound, in which a cyclodextrin is made to be present in a culture broth of actinomycetes; antitumor agents EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-02-02 US disclosed
US-20100021918-A1 METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING SPLICING DEFECTS AS INDEX EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-01-28 US disclosed
US-20100016315-A1 Iminopyridine Derivative and Use Thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2145886-A1 TWELVE-MEMBERED CYCLOMACROLACTAM DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2010-01-20 EP disclosed
US-20100007832-A1 LIQUID CRYSTAL DISPLAY DAI NIPPON PRINTING CO., LTD. (JP) 2010-01-14 US disclosed
US-20090326009-A1 Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity Santen Pharmaceutical Co., (JP) 2009-12-31 US disclosed
US-20090325817-A1 Polymer co-location in surface-attached biopolymers and arrays of biopolymers INTEL CORPORATION 2009-12-31 US disclosed
US-20090325819-A1 Density modification in arrays of surface-attached nucleic acid molecules INTEL CORPORATION 2009-12-31 US disclosed
EP-2136209-A1 METHOD FOR EXAMINATION OF ACTION OF ANTI-CANCER AGENT UTILIZING SPLICING DEFECT AS MEASURE Eisai R&D Management Co., Ltd. (JP) 2009-12-23 EP disclosed
EP-2131193-A1 METHOD FOR EXAMINATION OF ACTIVITY OF ANTI-CANCER AGENT EMPLOYING REDUCTION IN EXPRESSION LEVEL OF GENE AS MEASURE Eisai R&D Management Co., Ltd. (JP) 2009-12-09 EP disclosed
US-7622295-B2 Molecular microarrays and helical peptides INTEL CORPORATION 2009-11-24 US disclosed
US-7619100-B2 Physiologically active substances MERCIAN CORPORATION (JP) 2009-11-17 US disclosed
US-20090258796-A1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS RAJASEKARAN JOHN J 2009-10-15 US disclosed
US-7599041-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2009-10-06 US disclosed
US-20090247418-A1 OPTICAL DETECTION FOR ELECTRONIC MICROARRAYS INTEL CORPORATION 2009-10-01 US disclosed
EP-2093610-A1 PROCESS FOR PRODUCING LIQUID CRYSTAL DISPLAY ELEMENT Dai Nippon Printing Co., Ltd. (JP) 2009-08-26 EP disclosed
US-7576204-B2 Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same MERCIAN CORPORATION (JP) 2009-08-18 US disclosed
EP-2085380-A1 PROCESS FOR PRODUCTION OF 1-HYDROXY-19-NORCYCLOVITAMIN D DERIVATIVE AND INTERMEDIATE FOR THE PRODUCTION MERCIAN CORPORATION (JP) 2009-08-05 EP disclosed
US-7570331-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2009-08-04 US disclosed
US-20090192153-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan (JP) 2009-07-30 US disclosed
US-20090181985-A1 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-07-16 US disclosed
EP-2077262-A1 IMINOPYRIDINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-08 EP disclosed
US-7553525-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2009-06-30 US disclosed
US-7553521-B2 Liquid crystal displays DAI NIPPON PRINTING CO., LTD. (JP) 2009-06-30 US disclosed
US-7550503-B2 Physiologically active substances EISAI R& D MANAGEMENT CO., LTD. (JP) 2009-06-23 US disclosed
US-20090142865-A1 LIQUID CRYSTAL DISPLAY SAWATARI NAOKO 2009-06-04 US disclosed
US-20090118263-A1 Novel Adenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-07 US disclosed
US-20090111807-A1 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-04-30 US disclosed
US-7524978-B2 2-oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol ZEON CORPORATION (JP) 2009-04-28 US disclosed
US-20090105212-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan (JP) 2009-04-23 US disclosed
US-20090099216-A1 NOVEL ADENINE COMPOUND ASTRAZENECA AKTIEBOLAG A CORPORATION OF SWEDEN (SE) 2009-04-16 US disclosed
US-20090093381-A1 Solid phase electrochemical synthesis with controlled product cleavage INTEL CORPORATION 2009-04-09 US disclosed
US-20090066884-A1 LIQUID CRYSTAL DISPLAY AND PROCESS FOR PRODUCING THE SAME DAI NIPPON PRINTING CO., LTD. (JP) 2009-03-12 US disclosed
US-20090051854-A1 LIQUID CRYSTAL DISPLAY DAI NIPPON PRINTING CO., LTD. (JP) 2009-02-26 US disclosed
US-20090042973-A1 Inhibitors of aspartyl protease VERTEX PHARMACEUTICALS INCORPORATED 2009-02-12 US disclosed
US-7476758-B2 Process for preparing a phenylalanine derivative and intermediates thereof MITSUBISHI TANBE PHARMA CORPORATION (JP) 2009-01-13 US disclosed
WO-2009006580-A1 OPTIONALLY CONDENSED DIHYDROPYRIDINE, DIHYDROPYRIMIDINE AND DIHYDROPYRANE DERIVATIVES ACTING AS LATE SODIUM CHANNEL BLOCKERS CV THERAPEUTICS, INC. (US) 2009-01-08 WO disclosed
US-20090005260-A1 MULTIPLEX DATA COLLECTION AND ANALYSIS IN BIOANALYTE DETECTION INTEL CORPORATION 2009-01-01 US disclosed
US-20090000957-A1 ELECTROCHEMICAL SYNTHESIS AND ELECTRICAL DETECTION OF POLYMERS WITH GEL-BASED BIO CHIP INTEL CORPORATION 2009-01-01 US disclosed
US-20080318808-A1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS RAJASEKARAN JOHN J 2008-12-25 US disclosed
US-20080312317-A1 12 MEMBERED-RING MACROLACTAM DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-12-18 US disclosed
US-20080300388-A1 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2008-12-04 US disclosed
EP-1995242-A1 NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY Santen Pharmaceutical Co., Ltd (JP) 2008-11-26 EP disclosed
US-20080275059-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES KOTAKE YOSHIHIKO 2008-11-06 US disclosed
US-20080269240-A1 Novel Adenine Compound Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan (JP) 2008-10-30 US disclosed
US-20080262989-A1 MULTIPLEX DATA COLLECTION AND ANALYSIS IN BIOANALYTE DETECTION INTEL CORPORATION 2008-10-23 US disclosed
US-20080255146-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES MICROBIOPHARM JAPAN CO., LTD. (JP) 2008-10-16 US disclosed
US-20080241704-A1 Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same UBE INDUSTRIES, LTD (JP) 2008-10-02 US disclosed
US-20080242561-A1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS RAJASEKARAN JOHN J 2008-10-02 US disclosed
US-7425394-B2 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2008-09-16 US disclosed
EP-1966230-A1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS Intel Corporation (US) 2008-09-10 EP disclosed
EP-1375489-B1 MEDICINAL COMPOSITION CONTAINING 1,3-THIAZINE DERIVATIVE SHIONOGI & CO (JP) 2008-08-20 EP disclosed
US-7414064-B2 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. (US) 2008-08-19 US disclosed
WO-2008097370-A2 METHOD FOR HIGH THROUGHPUT, HIGH VOLUME MANUFACTURING OF BIOMOLECULE MICRO ARRAYS INTEL CORPORATION (US) 2008-08-14 WO disclosed
US-7410763-B2 Multiplex data collection and analysis in bioanalyte detection INTEL CORPORATION (US) 2008-08-12 US disclosed
EP-1952155-A2 METHOD AND CMOS-BASED DEVICE TO ANALYZE MOLECULES AND NANOMATERIALS BASED ON THE ELECTRICAL READOUT OF SPECIFIC BINDING EVENTS ON FUNCTIONALIZED ELECTRODES Intel Corporation (INTEL) (US) 2008-08-06 EP disclosed
EP-1944290-A1 NOVEL 1-2-DIHYDROQUINOLINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY SANTEN PHARMACEUTICAL CO., LTD. (JP) 2008-07-16 EP disclosed
US-20080161202-A1 Novel strategy for selective regulation of background surface property in microarray fabrication and method to eliminated self quenching in micro arrays INTEL CORPORATION 2008-07-03 US disclosed
US-20080157786-A1 Quality control methods for the manufacture of polymer arrays INTEL CORPORATION 2008-07-03 US disclosed
US-20080160635-A1 Method and apparatus for combined electrochemical synthesis and detection of analytes INTEL CORPORATION (US) 2008-07-03 US disclosed
EP-1939198-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-02 EP disclosed
EP-1939199-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-02 EP disclosed
EP-1939201-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-02 EP disclosed
EP-1939202-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-02 EP disclosed
EP-1939200-A1 NOVEL ADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-02 EP disclosed
US-20080145862-A1 Molecular microarrays and helical peptides INTEL CORPORATION 2008-06-19 US disclosed
WO-2008048222-A2 METHOD AND CMOS-BASED DEVICE TO ANALYZE MOLECULES AND NANOMATERIALS BASED ON THE ELECTRICAL READOUT OF SPECIFIC BINDING EVENTS ON FUNCTIONALIZED ELECTRODES INTEL CORPORATION (US) 2008-04-24 WO disclosed
EP-1906444-A2 Gettering device for ion capture Combimatrix Corporation (US) 2008-04-02 EP disclosed
US-20080070286-A1 Dna Participating in Hydroxylation of Macrolide Compound SANLI HOLDINGS CO., LTD. (JP) 2008-03-20 US disclosed
EP-1890187-A1 LIQUID CRYSTAL DISPLAY ELEMENT DAI NIPPON PRINTING CO., LTD. (JP) 2008-02-20 EP disclosed
US-20070292855-A1 Method and CMOS-based device to analyze molecules and nanomaterials based on the electrical readout of specific binding events on functionalized electrodes INTEL CORPORATION (US) 2007-12-20 US disclosed
EP-1849796-A1 ANTI-PENICILLIN RESISTANT PNEUMOCOCCI AGENT AND NOVEL 16-MEMBERED RING MACROLIDE DERIVATIVE Microbial Chemistry Research Foundation (JP) 2007-10-31 EP disclosed
US-7256178-B2 Physiologically active substances EISAI CO., LTD. (JP) 2007-08-14 US disclosed
WO-2007078868-A1 MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS INTEL CORPORATION (US) 2007-07-12 WO disclosed
US-20070154946-A1 Massively parallel synthesis of biopolymeric arrays INTEL CORPORATION 2007-07-05 US disclosed
US-20070155696-A1 Method for stabilizing macrolide compounds MERCIAN CORPORATION (JP) 2007-07-05 US disclosed
US-20070154653-A1 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2007-07-05 US disclosed
US-20070142445-A1 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives SYNGENTA CROP PROTECTION, INC. (US) 2007-06-21 US disclosed
US-20070122842-A1 Massively parallel synthesis of proteinaceous biomolecules INTEL CORPORATION 2007-05-31 US disclosed
US-20070122841-A1 Massively parallel synthesis of proteinaceous biomolecules INTEL CORPORATION 2007-05-31 US disclosed
US-20070048746-A1 Beam emitter, microfluidic channel, spectrometer and detector; binding between reporter molecules and analyte; microelectric mechanical system INTEL CORPORATION (US) 2007-03-01 US disclosed
CN-1916630-A Method for molecular and nano material based on the electric reading of concrete affair of functionalized electrode, and cmod based device INTEL CORP (US) 2007-02-21 CN disclosed
US-20070026165-A1 Liquid crystal display and manufacturing method of same DAI NIPPON PRINTING CO., LTD. (JP) 2007-02-01 US disclosed
EP-1434870-B1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID HOFFMANN LA ROCHE (CH) 2006-12-27 EP disclosed
WO-2006133042-A2 METHOD AND APPARATUS TO FABRICATE POLYMER ARRAYS ON PATTERNED WAFERS USING ELECTROCHEMICAL SYNTHESIS INTEL CORPORATION (US) 2006-12-14 WO disclosed
US-20060275927-A1 Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis INTEL CORPORATION (US) 2006-12-07 US disclosed
EP-1729365-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME Ube Industries, Ltd. (JP) 2006-12-06 EP disclosed
US-20060241171-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2006-10-26 US disclosed
EP-1715371-A1 LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2006-10-25 EP disclosed
US-20060235002-A1 Novel physiologically active substance EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-10-19 US disclosed
EP-1710244-A1 METHOD OF STABILIZING MACROLIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2006-10-11 EP disclosed
EP-1705247-A1 DNA PARTICIPATING IN HYDROXYLATION OF MACROLIDE COMPOUND MERCIAN CORPORATION (JP) 2006-09-27 EP disclosed
US-20060211696-A1 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-09-21 US disclosed
US-20060205960-A1 2-Oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol ZEON CORPORATION (JP) 2006-09-14 US disclosed
US-7078405-B2 Imidazo[1,2-b]pyridazine compound EISAI CO., LTD. (JP) 2006-07-18 US disclosed
US-20060082719-A1 Liquid crystal display and manufacturing method of the same DAI NIPPON PRINTING CO., LTD. (JP) 2006-04-20 US disclosed
US-7011960-B2 Substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acids HOFFMANN-LA ROCHE INC. (US) 2006-03-14 US disclosed
US-20060038949-A1 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2006-02-23 US disclosed
US-20060009439-A1 Novel physiologically active substances MERCIAN CORPORATION (JP) 2006-01-12 US disclosed
US-20050266177-A1 Liquid crystal display DAI NIPPON PRINTING CO., LTD. (JP) 2005-12-01 US disclosed
US-20050245514-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2005-11-03 US disclosed
US-20050233094-A1 Liquid crystal displays DAI NIPPON PRINTING CO., LTD. (JP) 2005-10-20 US disclosed
US-20050165107-A1 Process for preparing a phenylalanine derivative and intermediates thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2005-07-28 US disclosed
US-6916806-B2 Medicinal composition containing 1,3-thiazine derivative SHIONOGI & CO., LTD. (JP) 2005-07-12 US disclosed
EP-1548121-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-06-29 EP disclosed
EP-1185363-B1 SELF ASSEMBLING ARRAYS COMBIMATRIX CORP (US) 2005-06-15 EP disclosed
EP-1541570-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCE MERCIAN CORPORATION (JP) 2005-06-15 EP disclosed
EP-1535917-A1 2-OXABICYCLO 3.3.0 OCTANE COMPOUNDS, PROCESS FOR PRODUCING THE SAME, OPTICAL RESOLVER, METHOD OF SEPARATING DIASTEREOMER MIXTURE, AND METHOD OF OPTICALLY RESOLVING ALCOHOL Zeon Corporation (JP) 2005-06-01 EP disclosed
EP-1508570-A1 NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-02-23 EP disclosed
WO-2004113290-A1 SUBSTITUTED ALKYLAMIDES BAYER HEALTHCARE AG (DE) 2004-12-29 WO disclosed
EP-1478619-A1 A PROCESS FOR PREPARING A PHENYLALANINE DERIVATIVE AND INTERMEDIATES THEREOF TANABE SEIYAKU CO., LTD. (JP) 2004-11-24 EP disclosed
EP-1434870-A1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID F. HOFFMANN-LA ROCHE AG (CH) 2004-07-07 EP disclosed
US-20040116326-A1 Medicinal composition containing 1,3-thiazine derivative SHIONOGI & CO., LTD. (JP) 2004-06-17 US disclosed
US-20040097728-A1 Method for producing anellated tetrahydro-{1h}-triazoles BASF AKTIENGESELLSCHAFT (DE) 2004-05-20 US disclosed
US-6737544-B1 HEATING ABOVE MELTING POINT BASF AKTIENGESELLSCHAFT (DE) 2004-05-18 US disclosed
US-20040082781-A1 Bicyclic nitrogenous fused-ring compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-04-29 US disclosed
EP-1375489-A1 MEDICINAL COMPOSITION CONTAINING 1,3-THIAZINE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2004-01-02 EP disclosed
EP-1364952-A1 BICYCLIC NITROGENOUS FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2003-11-26 EP disclosed
US-6639070-B1 4-substituted 1,3,4-oxadiazines; herbicides BASF AKTIENGESELLSCHAFT (DE) 2003-10-28 US disclosed
EP-0926134-B1 Processes for producing alpha-cyanohydrin esters and alpha-hydroxy acids DAICEL CHEM (JP) 2003-09-17 EP disclosed
EP-0747389-B1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2003-09-10 EP disclosed
WO-2003072536-A1 A PROCESS FOR PREPARING A PHENYLALANINE DERIVATIVE AND INTERMEDIATES THEREOF TANABE SEIYAKU CO., LTD. (JP) 2003-09-04 WO disclosed
US-6602825-B1 Cyclization of an isocyanate with a thiourea and carbonic acid BASF AKTIENGESELLSCHAFT (DE) 2003-08-05 US disclosed
EP-1187819-B1 N-SUBSTITUTED PERHYDRO DIAZINE BASF AG (DE) 2003-07-23 EP disclosed
US-20030124552-A1 Biochips and method of screening using drug induced gene and protein expression profiling MOWYCAL LENDING, LLC 2003-07-03 US disclosed
US-20030119152-A1 Substituted 2-amino-3- (2-amino-phenylsulfanyl) -propionic acids HOFFMANN-LA ROCHE INC. 2003-06-26 US disclosed
EP-1315733-A2 METHOD FOR PRODUCING ANELLATED TETRAHYDRO-[1H]-TRIAZOLES BASF AKTIENGESELLSCHAFT (DE) 2003-06-04 EP disclosed
EP-0733633-B1 Heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-28 EP disclosed
EP-1034166-B1 SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES BASF AG (DE) 2003-05-02 EP disclosed
US-RE38090-E1 Antitumor activity; useful for treatment and prevention of cancers Matsuda, Akira (JP) 2003-04-22 US disclosed
WO-2003029477-A1 ENZYMATIC PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-AMINO-3-(2-AMINO-PHENYLSULFANYL)-PROPIONIC ACID F. HOFFMANN-LA ROCHE AG (CH) 2003-04-10 WO disclosed
EP-0657166-B1 Combination containing a quinoxaline and a nucleoside AVENTIS PHARMA GMBH (DE) 2003-04-09 EP disclosed
US-20030050438-A1 Electrochemical solid phase synthesis MONTGOMERY DONALD D (US) 2003-03-13 US disclosed
US-20030050437-A1 Electrochemical solid phase synthesis MONTGOMERY DONALD D (US) 2003-03-13 US disclosed
US-6528455-B1 Post or preemergence herbicides such as 3-(4-chloro-2-fluoro -5-(1-methoxycarbonyl-1-vinyloxy)phenyl)-1-methyl-6-trifluoro methyl-2,4-pyrimidinedione BASF AKTIENGESELLSCHAFT (DE) 2003-03-04 US disclosed
WO-2002090979-A1 BIOCHIPS AND METHOD OF SCREENING USING DRUG INDUCED GENE AND PROTEIN EXPRESSION PROFILING HISTATEK, INC. (US) 2002-11-14 WO disclosed
EP-1237879-A1 PHENOXY AND THIOPHENOXY ACRYLIC ACID COMPOUNDS AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-09-11 EP disclosed
US-6444111-B1 Electrochemical solid phase synthesis of polymers COMBIMATRIX CORPORATION 2002-09-03 US disclosed
WO-2000053625-A9 MICROARRAYS OF PEPTIDE AFFINITY PROBES FOR ANALYZING GENE PRODUCTS AND METHODS FOR ANALYZING GENE PRODUCTS COMBIMATRIX CORP (US) 2002-07-04 WO disclosed
EP-1218350-A1 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS BASF AKTIENGESELLSCHAFT (DE) 2002-07-03 EP disclosed
EP-0648718-B1 Polymeric binders for ceramic processing NALCO CHEMICAL CO (US) 2002-06-26 EP disclosed
US-6410756-B1 USING BLOCKING AGENTS INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2002-06-25 US disclosed
EP-0926135-B1 Processes for producing alpha-aminonitrile derivatives and alpha-amino acids DAICEL CHEM (JP) 2002-06-05 EP disclosed
EP-0891336-B1 SUBSTITUTED 1-METHYL-3-BENZYLURACILS BASF AG (DE) 2002-06-05 EP disclosed
US-20020045771-A1 Family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) 2002-04-18 US disclosed
US-6369057-B1 VIRICIDES, IN PARTICULAR AGAINST RETROVIRUSES, HUMAN IMMUNODEFICIENCY VIRUS (HIV) AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-09 US disclosed
EP-1187819-A1 N-SUBSTITUTED PERHYDRO DIAZINE BASF AKTIENGESELLSCHAFT (DE) 2002-03-20 EP disclosed
EP-1187820-A1 SUBSTITUTED UREAS BASF AKTIENGESELLSCHAFT (DE) 2002-03-20 EP disclosed
WO-2002020531-A2 METHOD FOR PRODUCING ANELLATED TETRAHYDRO-[1H]-TRIAZOLES BASF AKTIENGESELLSCHAFT (DE) 2002-03-14 WO disclosed
EP-1185363-A1 SELF ASSEMBLING ARRAYS Combimatrix Corporation (US) 2002-03-13 EP disclosed
WO-2000053311-A9 SELF ASSEMBLING ARRAYS COMBIMATRIX CORP (US) 2001-11-29 WO disclosed
EP-1157012-A1 1-ARYL-1,3,5-TRIAZINE-4-THIONE-2,6-DIONES, PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-11-28 EP disclosed
EP-0509398-B1 Quinoxalines, process for their preparation and their use AVENTIS PHARMA GMBH (DE) 2001-09-19 EP disclosed
EP-1127053-A1 NOVEL 1-ARYL-4-THIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
US-6280595-B1 Electrochemical solid phase synthesis COMBIMATRIX CORPORATION 2001-08-28 US disclosed
EP-1123266-A1 METHOD FOR DRYING PHENOXYMETHYLBENZOIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 2001-08-16 EP disclosed
US-6265418-B1 ANTICOAGULANTS UBE INDUSTRIES, LTD. (JP) 2001-07-24 US disclosed
WO-2001044204-A1 PHENOXY AND THIOPHENOXY ACRYLIC ACID COMPOUNDS AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-06-21 WO disclosed
US-6225313-B1 USE AS HERBICIDES AND FOR THE DESICCATION/DEFOLIATION OF PLANTS BASF AKTIENGESELLSCHAFT (DE) 2001-05-01 US disclosed
WO-2001025216-A1 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS BASF AKTIENGESELLSCHAFT (DE) 2001-04-12 WO disclosed
EP-0835248-B1 1-AMINO-3-BENZYLURACILS BASF AG (DE) 2001-02-21 EP disclosed
WO-2001000600-A1 N-SUBSTITUTED PERHYDRO DIAZINE BASF AKTIENGESELLSCHAFT (DE) 2001-01-04 WO disclosed
WO-2001000602-A1 SUBSTITUTED UREAS BASF AKTIENGESELLSCHAFT (DE) 2001-01-04 WO disclosed
EP-0910467-B1 ELECTROCHEMICAL SOLID PHASE SYNTHESIS OF POLYMERS COMBIMATRIX CORP (US) 2001-01-03 EP disclosed
US-6150303-A Substituted 3-phenylisoxazolines BASF AKTIENGESELLSCHAFT (DE) 2000-11-21 US disclosed
EP-1048072-A1 GETTERING DEVICE FOR ION CAPTURE Combimatrix Corporation (US) 2000-11-02 EP disclosed
WO-2000053625-A2 MICROARRAYS OF PEPTIDE AFFINITY PROBES FOR ANALYZING GENE PRODUCTS AND METHODS FOR ANALYZING GENE PRODUCTS COMBIMATRIX CORPORATION (US) 2000-09-14 WO disclosed
WO-2000053311-A1 SELF ASSEMBLING ARRAYS COMBIMATRIX CORPORATION (US) 2000-09-14 WO disclosed
EP-1034166-A1 SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES BASF AKTIENGESELLSCHAFT (DE) 2000-09-13 EP disclosed
WO-2000051721-A2 COMBINATORIAL CHELATOR ARRAY COMBIMATRIX CORPORATION (US) 2000-09-08 WO disclosed
WO-2000050409-A1 1-ARYL-1,3,5-TRIAZINE-4-THIONE-2,6-DIONES, PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2000-08-31 WO disclosed
US-6111128-A IN THE PRESENCE OF A METAL CATALYST, REACTING AN ENOL ESTER OF GIVEN FORMULA OR OXIME ESTER WITH A CARBONYL COMPOUND AND CYANOGENATION AGENT TO FORM AN ALPHA-CYANOHYDRIN ESTER WHICH IS HYDROLYZED TO FORM ALPHA-HYDROXY ACIDS; EFFICIENCY DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-29 US disclosed
US-6100419-A Processes for producing α-aminonitrile derivatives and α-amino acids DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-6093302-A Electrochemical solid phase synthesis COMBIMATRIX CORPORATION (US) 2000-07-25 US disclosed
EP-1020467-A1 N-ACYLAMINO ACID AMIDE COMPOUNDS AND INTERMEDIATES FOR PREPARATION THEREOF UBE INDUSTRIES LIMITED (JP) 2000-07-19 EP disclosed
WO-2000026194-A1 NOVEL 1-ARYL-4-THIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2000-05-11 WO disclosed
EP-0998468-A1 SUBSTITUTED 3-PHENYL ISOXAZOLINES BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 EP disclosed
WO-2000023413-A1 METHOD FOR DRYING PHENOXYMETHYLBENZOIC ACIDS BASF AKTIENGESELLSCHAFT (DE) 2000-04-27 WO disclosed
EP-0977570-A1 QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS BAYER AG (DE) 2000-02-09 EP disclosed
EP-0971904-A1 NOVEL 1-AMINO-3 BENZYL URACILS BASF AKTIENGESELLSCHAFT (DE) 2000-01-19 EP disclosed
WO-1999035688-A1 GETTERING DEVICE FOR ION CAPTURE COMBIMATRIX CORPORATION (US) 1999-07-15 WO disclosed
EP-0926134-A2 Processes for producing alpha-cyanohydrin esters and alpha-hydroxy acids Daicel Chemical Industries, Ltd. (JP) 1999-06-30 EP disclosed
EP-0926135-A2 Processes for producing alpha-aminonitrile derivatives and alpha-amino acids Daicel Chemical Industries, Ltd. (JP) 1999-06-30 EP disclosed
EP-0910467-A1 ELECTROCHEMICAL SOLID PHASE SYNTHESIS OF POLYMERS Combimatrix Corporation (US) 1999-04-28 EP disclosed
WO-1999018082-A1 NOVEL SUBSTITUTED PYRIDAZINONES BASF AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed
WO-1999014201-A1 SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES BASF AKTIENGESELLSCHAFT (DE) 1999-03-25 WO disclosed
US-5869675-A INDUCE NEURITOGENESIS; TREATING DEMENTIA THE KITASATO INSTITUTE (JP) 1999-02-09 US disclosed
WO-1999005130-A1 SUBSTITUTED 3-PHENYL ISOXAZOLINES BASF AKTIENGESELLSCHAFT (DE) 1999-02-04 WO disclosed
EP-0891336-A1 SUBSTITUTED 1-METHYL-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1999-01-20 EP disclosed
JP-H10310546-A PRODUCTION OF MONOHALOACETONE DAICEL CHEM IND LTD 1998-11-24 JP disclosed
WO-1998042682-A1 NOVEL 1-AMINO-3 BENZYL URACILS BASF AKTIENGESELLSCHAFT (DE) 1998-10-01 WO disclosed
WO-1998032442-A1 QUINOXALINE IN TRIPLE COMBINATION WITH PROTEASE INHIBITORS AND REVERSE TRANSCRIPTASE INHIBITORS AS MEDICINES FOR TREATING AIDS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-30 WO disclosed
US-5763418-A NUCLEOTIDE ANTITUMOR AGENTS Matsuda, Akira (JP) 1998-06-09 US disclosed
US-5753664-A ANTITUMOR AGENTS, PYRIMIDONES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-05-19 US disclosed
WO-1998017656-A1 A FAMILY OF CANADENSOL TAXANES, THE SEMI-SYNTHETIC PREPARATION AND THERAPEUTIC USE THEREOF INSTITUTE ARMAND-FRAPPIER (CA) 1998-04-30 WO disclosed
EP-0835248-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1998-04-15 EP disclosed
WO-1998001221-A1 ELECTROCHEMICAL SOLID PHASE SYNTHESIS OF POLYMERS COMBIMATRIX CORPORATION (US) 1998-01-15 WO disclosed
WO-1997035845-A1 SUBSTITUTED 1-METHYL-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-10-02 WO disclosed
WO-1997001543-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-01-16 WO disclosed
EP-0747389-A1 3'-SUBSTITUTED NUCLEOSIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-12-11 EP disclosed
EP-0733633-A1 Heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-09-25 EP disclosed
EP-0728481-A2 Use of quinoxaline and protease inhibitors in a composition for the treatment of AIDS and/or HIV infections BAYER AG (DE) 1996-08-28 EP disclosed
EP-0723957-A1 Lactacystin derivatives THE KITASATO INSTITUTE (JP) 1996-07-31 EP disclosed
US-5525665-A HYDROLYZED COPOLYMER MADE FROM MONOMERS HAVING ESTER OR AMIDE FUNCTIONAL GROUPS NALCO CHEMICAL COMPANY (US) 1996-06-11 US disclosed
US-5487855-A ALUMINA CERAMICS WITH POLYMER BINDERS, SLURRYING, DRYING AND SLIP CASTING THEN FIRING NALCO CHEMICAL COMPANY (US) 1996-01-30 US disclosed
US-5480879-A ANTIBACTERIAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1996-01-02 US disclosed
EP-0657166-A1 Combination containing a quinoxaline and a nucleoside HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-14 EP disclosed
EP-0648718-A2 Polymeric binders for ceramic processing NALCO CHEMICAL COMPANY (US) 1995-04-19 EP disclosed
US-5358911-A Slurrying ceramic powder with hydrolyzed polymer of an ester and an amide, drying, compacting, heating NALCO CHEMICAL COMPANY (US) 1994-10-25 US disclosed
JP-H06250391-A PATTERN FORMING MATERIAL AND NOVEL AROMATIC ISOPROPENYL CARBONATE AIBAITSU KK 1994-09-09 JP disclosed
JP-H06250392-A RESIST PATTERN FORMING METHOD AIBAITSU KK 1994-09-09 JP disclosed
EP-0592868-A1 Quinolonecarboxylic acids BAYER AG (DE) 1994-04-20 EP disclosed
EP-0348166-B1 Adhesive composition containing a thiocarboxylic acid or a derivative thereof KURARAY CO (JP) 1994-04-20 EP disclosed
EP-0591808-A1 Quinolonecarboxylic acids BAYER AG (DE) 1994-04-13 EP disclosed
US-5254198-A Water-resistant, high strength bond; dental applications KURARAY CO., LTD. (JP) 1993-10-19 US disclosed
US-5186783-A High strength bonding, dentistry KURARAY CO., LTD. (JP) 1993-02-16 US disclosed
EP-0509398-A1 Quinoxalines, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-21 EP disclosed
EP-0348166-A2 Adhesive composition containing a thiocarboxylic acid or a derivative thereof KURARAY CO., LTD. (JP) 1989-12-27 EP disclosed
US-4859759-A Siloxane containing benzotriazolyl/tetraalkylpiperidyl substituent KIMBERLY-CLARK CORPORATION (US) 1989-08-22 US disclosed
US-4232015-A ANTIINFLAMMATORY AGENTS ROUSSEL UCLAF (FR) 1980-11-04 US disclosed
US-4144388-A Film-forming and thermocurable vinyl alcohol-substituted acrylamide copolymers and process for production thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1979-03-13 US disclosed
US-3999991-A LIGHT SENSITIVE MATERIALS; SILVER HALIDE EMULSION LAYER FUJI PHOTO FILM CO., LTD. (JA) 1976-12-28 US disclosed
US-3999991-A LIGHT SENSITIVE MATERIALS; SILVER HALIDE EMULSION LAYER FUJI PHOTO FILM CO., LTD. (JA) 1976-12-28 US disclosed